Spinal Tech Archives - Page 250 of 1223

Medtronic's weekly US sales drop 60%: 7 COVID-19 update

Medtronic updated guidance on how the COVID-19 pandemic is affecting its business and the company's current financial position.

Life Spine lateral fixation device gains FDA clearance

The FDA provided Life Spine 510(k) clearance for its Prolift lateral fixated system on April 21.

Former Medtronic exec joins GTX Medical BV as chief technology officer

John Murphy, PhD, on April 20 was appointed chief technology officer of GTX Medical BV, a device company specializing in neuromodulation therapies for spinal cord injuries.

$4.7M SBA loan given to Conformis to mitigate economic impact of COVID-19

Orthopedic implant manufacturer Conformis recently received a $4.7 million loan through the Small Business Association to help maintain liquidity during the COVID-19 pandemic.

Precision Spine launches posterior fixation device to lower muscle disruption

Precision Spine on April 20 launched Reform MC, a posterior lumbar fusion system.

Astura Medical gains clearance for lateral lumbar interbody fusion device

The FDA on April 14 provided Astura Medical 510(k) clearance for its Sirion lateral lumbar interbody fusion system.

Spinal allografts market expected to hit $3.9B by 2025

The spinal allograft market is expected to increase from $2.5 billion in 2019 to $3.9 billion by the end of 2025, according to new data published by ReportLinker.

19 spine devices receive FDA 510(k) clearance in March

The FDA cleared 19 spine devices in March 2020.

How COVID-19 affected Johnson & Johnson's Q1 orthopedics sales and what to expect for the future

Johnson & Johnson reported orthopedic sales in the U.S. were down 5.2 percent in the first quarter and all subspecialty lines reported drops as well due to the coronavirus.

Ossio, Smith+Nephew shake up leadership teams & more: 8 device company notes

Here are eight key notes on spine and orthopedic device companies: